Table 1—

Comparison of patients without and with SMI

No SMISMIP
n10530
Age (years)52.6 ± 10.153.6 ± 10.80.660
Men (%)68900.015
Diabetes duration (years)24.2 ± 12.824.9 ± 11.60.803
HbA1c (%)9.2 ± 1.78.9 ± 1.30.552
BMI (kg/m2)24.1 ± 3.425.3 ± 3.60.074
Patients reaching 85% of MHR (%)46570.289
Total cholesterol (mg/dl)204 ± 40218 ± 350.108
HDL cholesterol (mg/dl)63 ± 1959 ± 170.316
LDL cholesterol (mg/dl)122 ± 35136 ± 330.047
Non-HDL cholesterol (mg/dl)142 ± 38159 ± 380.034
Ratio of total to HDL cholesterol3.54 ± 1.334.03 ± 1.430.086
Subjects with triglycerides >150 mg/dl (%)17170.951
Lipid-lowering medication (%)14230.237
Systolic blood pressure (mmHg)133 ± 16136 ± 160.309
Diastolic blood pressure (mmHg)76 ± 976 ± 80.805
Antihypertensive treatment (%)49670.080
Microangiopathy (%)*31630.001
Retinopathy (%)21430.019
PAD (%)13370.004
Family history of CAD (%)9300.003
Smokers (%)40300.319
Number of cardiovascular risk factors (%)
 ≤124230.343
 25543
 ≥32133
  • Data are means ± SD, unless noted otherwise.

  • *

    * Nephropathy and/or retinopathy;

  • risk factors included family history of CAD, smoking, dyslipidemia (lipid-lowering therapy and/or LDL cholesterol >130 mg/dl and/or triglycerides >150 mg/dl and/or HDL cholesterol <40 mg/dl), and hypertension (antihypertensive treatment and/or blood pressure >130/80 mmHg). MHR, maximal predicted heart rate for age.